Ex Solvay CEO Starts New Biotech
Monday, December 04, 2006 9:00:00 AM PDT | VentureDeal Staff
ATLANTA, GA -- Prominent CEO Harold Shlevin is launching a biopharmaceutical startup to focus on diseases of the central nervous system.
His company, called Tikvah Therapeutics, will explore new uses for already approved compounds in order to shorten product development timelines.
The company expects to receive a loan from Georgia's Life Sciences Facilities Fund to assist in securing lab and office facilities. It was founded with support of Paramount Biosciences.
Email Page | Print Page